No Data
No Data
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Intrinsic Value Is Potentially 96% Above Its Share Price
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Stock Price Dropped 7.1% Last Week; Private Companies Would Not Be Happy
Allist Pharmaceuticals' Q3 Profit Soars 101%, Operating Income Jumps 60%
Shanghai Alice Pharmaceutical Technology Co., Ltd. Report for the Third Quarter of 2024
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): Net income in the first three quarters was 1.063 billion yuan, a year-on-year increase of 158.99%.
gelonhui October 24th | shanghai allist pharmaceuticals co., ltd. (688578.SH) announced its third quarter report for 2024, with the company's revenue in the first three quarters of 2.533 billion yuan, an 87.97% year-on-year increase; net income attributable to shareholders of the listed company was 1.063 billion yuan, a 158.99% year-on-year increase; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 1.011 billion yuan, a 165.98% year-on-year increase; basic earnings per share was 2.36 yuan.
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Shares Bounce 43% But Its Business Still Trails The Market
No Data
No Data